Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 18453567)

1.

HIV-induced changes in T cell signaling pathways.

Schweneker M, Favre D, Martin JN, Deeks SG, McCune JM.

J Immunol. 2008 May 15;180(10):6490-500.

2.

T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsiveness.

Downey JS, Attaf M, Moyle G, Gazzard B, Gotch F, Imami N.

AIDS. 2011 Oct 23;25(16):1981-6. doi: 10.1097/QAD.0b013e32834b35a9.

PMID:
21811141
3.
4.

HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.

Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI.

Cytometry B Clin Cytom. 2007 Jan 15;72(1):14-21.

PMID:
17041945
5.

Distribution of naïve (CD45RA+) and memory (CD45RO+) T-cells in HIV-infected Puerto Rican population.

Roman M, Rodriguez JW, Pagán NO, Rios-Olivares E, Amill A, Hunter R.

P R Health Sci J. 2002 Sep;21(3):195-201.

PMID:
12243109
6.

CD4+ and CD8+ T cell receptor repertoire perturbations with normal levels of T cell receptor excision circles in HIV-infected, therapy-naive adolescents.

Pahwa S, Chitnis V, Mitchell RM, Fernandez S, Chandrasekharan A, Wilson CM, Douglas SD.

AIDS Res Hum Retroviruses. 2003 Jun;19(6):487-95.

PMID:
12882658
7.

Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells.

Tsalimalma K, Kordossis T, Choremi-Papadopoulou E.

Scand J Immunol. 2011 Mar;73(3):256-65. doi: 10.1111/j.1365-3083.2010.02502.x.

PMID:
21204901
8.

Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.

Plana M, García F, Gallart T, Tortajada C, Soriano A, Palou E, Maleno MJ, Barceló JJ, Vidal C, Cruceta A, Miró JM, Gatell JM.

AIDS. 2000 Sep 8;14(13):1921-33.

PMID:
10997396
9.

CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy.

Giovannetti A, Ensoli F, Mazzetta F, De Cristofaro M, Pierdominici M, Muratori DS, Fiorelli V, Aiuti F.

Clin Exp Immunol. 1999 Oct;118(1):87-94.

10.

Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.

Chun TW, Justement JS, Moir S, Hallahan CW, Ehler LA, Liu S, McLaughlin M, Dybul M, Mican JM, Fauci AS.

Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):253-8.

11.

HIV infection perturbs interleukin-7 signaling at the step of STAT5 nuclear relocalization.

Landires I, Bugault F, Lambotte O, de Truchis P, Slama L, Danckaert A, Delfraissy JF, Thèze J, Chakrabarti LA.

AIDS. 2011 Sep 24;25(15):1843-53. doi: 10.1097/QAD.0b013e32834a3678.

PMID:
21716071
12.
13.
15.

HIV-1 infection abrogates CD8+ T cell mitogen-activated protein kinase signaling responses.

Crawford TQ, Ndhlovu LC, Tan A, Carvidi A, Hecht FM, Sinclair E, Barbour JD.

J Virol. 2011 Dec;85(23):12343-50. doi: 10.1128/JVI.05682-11. Epub 2011 Sep 21.

16.

Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells.

Lécuroux C, Girault I, Boutboul F, Urrutia A, Goujard C, Meyer L, Lambotte O, Chaix ML, Martinez V, Autran B, Sinet M, Venet A; ANRS PRIMO Cohort, ANRS HIC Study Group; ANRS ALT Cohort; ANRS HIC Study Group.

AIDS. 2009 Aug 24;23(13):1649-58. doi: 10.1097/QAD.0b013e32832e6634.

PMID:
19617814
17.

Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.

Piriou E, Jansen CA, van Dort K, De Cuyper I, Nanlohy NM, Lange JM, van Oers MH, Miedema F, van Baarle D.

J Immunol. 2005 Aug 1;175(3):2010-7.

18.
19.

Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.

D'Souza M, Fontenot AP, Mack DG, Lozupone C, Dillon S, Meditz A, Wilson CC, Connick E, Palmer BE.

J Immunol. 2007 Aug 1;179(3):1979-87.

20.

HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment.

Rueda CM, Velilla PA, Chougnet CA, Montoya CJ, Rugeles MT.

PLoS One. 2012;7(1):e30307. doi: 10.1371/journal.pone.0030307. Epub 2012 Jan 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk